Koch Industries, run by controversial conservative billionaires Charles and David Koch, has acquired Irish medical devicemaker Protek Medical through its subsidiary Molex, the company recently announced.
A federal appeals court ruled Friday that Actavis must continue to sell an Alzheimer's drug it wanted to pull off the market to limit competition from generics. It's a case with potential implications for pharmaceutical companies and patients nationwide, experts say.
Johnson & Johnson expects a lucrative return from its pharmaceutical business, with plans to seek approval by 2019 for more than 10 new products, each with the potential to top $1 billion in annual sales.
Strong performance in McKesson Corp.'s North American pharmaceuticals business drove rising revenue for the San Francisco-based company in the fourth quarter of its fiscal year.
Strong sales of Premier's software and a move into the direct-sourcing business led to double-digit revenue growth in the third quarter, but increased costs and investment losses led to a sharp decrease in profit.
Becton, Dickinson and Co., a major producer of medical supplies, devices and equipment, reported a notable decrease in earnings in the second quarter because of losses from investments and the strong dollar's effect on international revenue.
Drug shortages, such as those involving saline solution and the antibiotic piperacillin/tazobactam that are currently challenging hospitals, represent a complex problem that affects the ability of hospitals and other healthcare providers to treat their most vulnerable patients. Though recent...
NuVasive is officially operating with a new chief executive, and the San Diego-based manufacturer of spine devices posted a sizable turnaround in the first quarter thanks to favorable legal developments.
Henry Schein, a major provider of supplies for medical, dental and veterinary offices, reported a slight uptick in earnings as growth in its medical business outpaced its dental stronghold in the first quarter.
MedAssets, a healthcare group purchasing and revenue-cycle management company, reported lower income for the first three months of 2015, the second quarter since the company acquired healthcare consultancy Sg2.
Cardinal Health reported a jump in earnings for the third quarter of its fiscal year, fueled mostly by growth in its pharmaceutical segment.
Acquisitions, restructuring and rising interest expenses left Laboratory Corporation of America Holdings with falling income despite slightly higher revenue in its first quarter.